Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$32.52 - $52.33 $7,479 - $12,035
-230 Reduced 0.89%
25,685 $1.34 Million
Q4 2023

Feb 13, 2024

SELL
$30.85 - $37.09 $6,571 - $7,900
-213 Reduced 0.82%
25,915 $922,000
Q3 2023

Nov 13, 2023

BUY
$31.69 - $39.25 $17,746 - $21,980
560 Added 2.19%
26,128 $875,000
Q2 2023

Aug 04, 2023

SELL
$29.0 - $38.37 $5,684 - $7,520
-196 Reduced 0.76%
25,568 $960,000
Q1 2023

May 12, 2023

BUY
$23.85 - $31.34 $2,718 - $3,572
114 Added 0.44%
25,764 $755,000
Q4 2022

Feb 10, 2023

SELL
$17.65 - $27.37 $3,494 - $5,419
-198 Reduced 0.77%
25,650 $675,000
Q3 2022

Nov 14, 2022

BUY
$22.62 - $32.54 $6,469 - $9,306
286 Added 1.12%
25,848 $600,000
Q2 2022

Aug 12, 2022

SELL
$22.88 - $39.45 $25,122 - $43,316
-1,098 Reduced 4.12%
25,562 $644,000
Q1 2022

May 13, 2022

SELL
$31.69 - $43.29 $51,781 - $70,735
-1,634 Reduced 5.78%
26,660 $1.02 Million
Q4 2021

Feb 11, 2022

SELL
$35.2 - $52.6 $31,504 - $47,077
-895 Reduced 3.07%
28,294 $1.11 Million
Q3 2021

Nov 12, 2021

SELL
$46.35 - $59.75 $45,886 - $59,152
-990 Reduced 3.28%
29,189 $1.42 Million
Q2 2021

Aug 13, 2021

SELL
$47.2 - $67.81 $6,702 - $9,629
-142 Reduced 0.47%
30,179 $1.58 Million
Q1 2021

May 07, 2021

BUY
$30.93 - $59.48 $120,224 - $231,198
3,887 Added 14.7%
30,321 $1.68 Million
Q4 2020

Feb 12, 2021

SELL
$18.53 - $31.5 $8,672 - $14,742
-468 Reduced 1.74%
26,434 $816,000
Q3 2020

Nov 04, 2020

SELL
$14.68 - $19.12 $8,984 - $11,701
-612 Reduced 2.22%
26,902 $499,000
Q2 2020

Aug 12, 2020

BUY
$8.5 - $15.82 $8,661 - $16,120
1,019 Added 3.85%
27,514 $380,000
Q1 2020

May 04, 2020

SELL
$7.25 - $19.22 $11,092 - $29,406
-1,530 Reduced 5.46%
26,495 $243,000
Q4 2019

Feb 05, 2020

BUY
$13.77 - $19.2 $3,552 - $4,953
258 Added 0.93%
28,025 $488,000
Q3 2019

Nov 08, 2019

SELL
$14.93 - $19.83 $2,881 - $3,827
-193 Reduced 0.69%
27,767 $420,000
Q2 2019

Aug 13, 2019

BUY
$15.01 - $18.89 $2,431 - $3,060
162 Added 0.58%
27,960 $528,000
Q1 2019

May 06, 2019

SELL
$16.23 - $20.29 $7,936 - $9,921
-489 Reduced 1.73%
27,798 $487,000
Q4 2018

Feb 13, 2019

SELL
$10.77 - $18.44 $2,347 - $4,019
-218 Reduced 0.76%
28,287 $492,000
Q3 2018

Nov 09, 2018

BUY
$9.1 - $14.8 $40,713 - $66,215
4,474 Added 18.62%
28,505 $403,000
Q2 2018

Aug 08, 2018

BUY
$9.6 - $14.6 $230,697 - $350,852
24,031 New
24,031 $233,000

Others Institutions Holding VCEL

About Vericel Corp


  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.76B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.